We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Compendia Bioscience and Ingenuity Partner to Integrate Cancer Gene Signature Data with Network Analysis Tools

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Compendia Bioscience and Ingenuity Systems® have announced the integration of their flagship products Oncomine™ Professional and Ingenuity Pathways Analysis.

These integrated products will allow users to navigate directly from cancer gene signatures discovered in Oncomine Professional to the curated pathway information available from Ingenuity Pathways Analysis (IPA).

Oncomine Professional is a growing compendium of transcriptome profiles coupled with analysis functions and a web application for data mining and visualization.

Comprised of thousands of profiles representing every major type of cancer, Oncomine Professional was developed to exploit this data for therapeutic target discovery, validation, and prioritization.

Ingenuity Pathways Analysis is a software application that can enable biologists and bioinformaticians to identify the biological mechanisms, pathways, and functions most relevant to their experimental datasets or genes of interest.